Skip to main content
Equibles

Farther Finance Advisors, LLC

Position in MNPR — Monopar Therapeutics

CIK 1992825 SAN FRANCISCO, CA
Back to MNPR Full portfolio

Position in MNPR

as of Sep 30, 2026 · filed Oct 8, 2026
Position Value
$1,912
-$310 QoQ
Shares Held
24
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#2
of 3 holders
Holding Since
Jun 2026
2 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in MNPR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Sep 30, 2026

Farther Finance Advisors, LLC holds $27,307,338 across 327 Biotechnology names. MNPR ranks #203 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 9,471 $4,951,533
2 MRNA
Moderna, Inc.
 17,622 $3,393,468
3 HALO
Halozyme Therapeutics, Inc.
 11,074 $1,222,569
4 REGN
Regeneron Pharmaceuticals, Inc.
 1,534 $1,163,186
5 INCY
Incyte Corp
 9,256 $1,123,215
6 EXEL
Exelixis, Inc.
 18,290 $1,068,318
7 RVMD
Revolution Medicines, Inc.
 4,848 $995,100
8 ARWR
Arrowhead Pharmaceuticals, Inc.
 12,147 $795,021

All Filings in MNPR

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-09-30 $1,912 24
2026-06-30 $2,222 24